Last reviewed · How we verify

NCT04164342: DOUCREA

Prevalence of Chronic Pain and Its Risk Factors After a Surgical Intensive Care Unit Stay. Prospective Observational Cohort

Completed NA Last updated 27 July 2022
What this trial tests

NA trial testing surveys in Pain, Chronic in 150 participants. Completed in 26 July 2022.

Timeline
27 November 2019
Primary endpoint
25 June 2021
26 July 2022

Quick facts

Lead sponsorUniversity Hospital, Angers
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment150
Start date27 November 2019
Primary completion25 June 2021
Estimated completion26 July 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Angers

Who can join

18 and older, any sex, with Pain, Chronic or Critically Ill. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this observational, prospective study is to evaluate the incidence of chronic pain at 3 months after ICU discharge in patients with a prolonged ICU stay (i.e. ≥3 days). Investigators will assess the proportion of patients with chronic pain (defined according to the Brief Pain Inventory questionnaire), by interview at 3 months after ICU discharge. All data potentially associated with chronic pain will be collected, including the type of surgery, the acute pain (intensity and duration) during the ICU stay, the type and dose of opioids received, patients comorbidity... Patients will be follow-up at 6 and 12 months to identify impact on quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of surveys

Trials testing the same drug.

Other recruiting trials for Pain, Chronic

Currently open trials in the same condition.

Other University Hospital, Angers trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04164342.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing